Related references
Note: Only part of the references are listed.The Effects of Repeated Morphine Treatment on the Endogenous Cannabinoid System in the Ventral Tegmental Area
Hong Zhang et al.
FRONTIERS IN PHARMACOLOGY (2021)
Effects of inflammatory pain on CB1 receptor in the midbrain periaqueductal gray
Adrianne R. Wilson-Poe et al.
PAIN REPORTS (2021)
Cannabinoid-2 Agonism with AM2301 Mitigates Morphine-Induced Respiratory Depression
Beth M. Wiese et al.
CANNABIS AND CANNABINOID RESEARCH (2021)
Medical cannabis for the reduction of opioid dosage in the treatment of non-cancer chronic pain: a systematic review
Babasola O. Okusanya et al.
SYSTEMATIC REVIEWS (2020)
Synthetic cannabinoid use among college students
Eva M. Mathews et al.
ADDICTIVE BEHAVIORS (2019)
Acute Cannabis Toxicity
Kei U. Wong et al.
PEDIATRIC EMERGENCY CARE (2019)
Synthetic peripherally-restricted cannabinoid suppresses chemotherapy-induced peripheral neuropathy pain symptoms by CB1 receptor activation
Yatendra Mulpuri et al.
NEUROPHARMACOLOGY (2018)
Peripherally restricted cannabinoid 1 receptor agonist as a novel analgesic in cancer-induced bone pain
Hong Zhang et al.
PAIN (2018)
Association Between US State Medical Cannabis Laws and Opioid Prescribing in the Medicare Part D Population
Ashley C. Bradford et al.
JAMA INTERNAL MEDICINE (2018)
(R)-N-(1-Methyl-2-hydroxyethyl)-13-(S)-methyl-arachidonamide (AMG315): A Novel Chiral Potent Endocannabinoid Ligand with Stability to Metabolizing Enzymes
Yingpeng Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Synthetic and Non-synthetic Cannabinoid Drugs and Their Adverse Effects-A Review From Public Health Prospective
Koby Cohen et al.
FRONTIERS IN PUBLIC HEALTH (2018)
Emerging Evidence for Cannabis' Role in Opioid Use Disorder
Beth Wiese et al.
CANNABIS AND CANNABINOID RESEARCH (2018)
Anti-nociceptive interactions between opioids and a cannabinoid receptor 2 agonist in inflammatory pain
Matthew B. Yuill et al.
MOLECULAR PAIN (2017)
In Vitro and In Vivo Profile of PPL-101and PPL-103: Mixed Opioid Partial agonist analgesics with low abuse Potential
Taline V. Khroyan et al.
FRONTIERS IN PSYCHIATRY (2017)
Synthetic cannabinoid induced acute respiratory depression: Case series and literature review
Mark Henry Alon et al.
RESPIRATORY MEDICINE CASE REPORTS (2017)
CB1 Receptor Antagonism in the Bed Nucleus of the Stria Terminalis Interferes With Affective Opioid Withdrawal in Rats
Kiri L. Wills et al.
BEHAVIORAL NEUROSCIENCE (2017)
Cannabis as a Substitute for Opioid-Based Pain Medication: Patient Self-Report
Amanda Reiman et al.
CANNABIS AND CANNABINOID RESEARCH (2017)
Factors driving the diffusion of medical marijuana legalisation in the United States
Ashley C. Bradford et al.
DRUGS-EDUCATION PREVENTION AND POLICY (2017)
A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment
Robert J. Tait et al.
CLINICAL TOXICOLOGY (2016)
The Effect of Medicinal Cannabis on Pain and Quality-of-Life Outcomes in Chronic Pain: A Prospective Open-label Study
Simon Haroutounian et al.
CLINICAL JOURNAL OF PAIN (2016)
Peripherally Selective Cannabinoid 1 Receptor (CB1R) Agonists for the Treatment of Neuropathic Pain
Herbert H. Seltzman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Effect of Pharmacological Modulation of the Endocannabinoid System on Opiate Withdrawal: A Review of the Preclinical Animal Literature
Kiri L. Wills et al.
FRONTIERS IN PHARMACOLOGY (2016)
Splendor in the Grass? A Pilot Study Assessing the Impact of Medical Marijuana on Executive Function
Staci A. Gruber et al.
Frontiers in Pharmacology (2016)
A Survey of Synthetic Cannabinoid Consumption by Current Cannabis Users
Erik W. Gunderson et al.
SUBSTANCE ABUSE (2014)
Cannabinoid Transmission in the Prelimbic Cortex Bidirectionally Controls Opiate Reward and Aversion Signaling through Dissociable Kappa Versus μ-Opiate Receptor Dependent Mechanisms
Tasha Ahmad et al.
JOURNAL OF NEUROSCIENCE (2013)
The periaqueductal gray contributes to bidirectional enhancement of antinociception between morphine and cannabinoids
Adrianne R. Wilson-Poe et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2013)
Cannabinoid CB2 receptor attenuates morphine-induced inflammatory responses in activated microglial cells
Stefania Merighi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Synthetic Cannabis and Respiratory Depression
Felecia N. Jinwala et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2012)
DISTRIBUTION OF CB1 CANNABINOID RECEPTORS AND THEIR RELATIONSHIP WITH MU-OPIOID RECEPTORS IN THE RAT PERIAQUEDUCTAL GRAY
A. R. Wilson-Poe et al.
NEUROSCIENCE (2012)
In Vivo Characterization of MMP-2200, a Mixed δ/μ Opioid Agonist, in Mice
John J. Lowery et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Characterization of cannabinoid-1 receptors in the locus coeruleus: Relationship with mu-opioid receptors
Jillian L. Scavone et al.
BRAIN RESEARCH (2010)
Functional Interactions between Endogenous Cannabinoid and Opioid Systems: Focus on Alcohol, Genetics and Drug-Addicted Behaviors
J. A. Lopez-Moreno et al.
CURRENT DRUG TARGETS (2010)
Cellular Mechanisms Underlying the Interaction between Cannabinoid and Opioid System
D. Parolaro et al.
CURRENT DRUG TARGETS (2010)
Effect of low doses of Δ9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats
LA Parker et al.
PSYCHOPHARMACOLOGY (2004)
Δ9-Tetrahydrocannabinol-induced conditioned place preference and intracerebroventricular self-administration in rats
D Braida et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
A cannabinoid receptor antagonist attenuates conditioned place preference but not behavioural sensitization to morphine
ME Singh et al.
BRAIN RESEARCH (2004)
Analysis of the respiratory effects of cannabinoids in rats
K Schmid et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2003)
The peripheral sympathetic nervous system is the major target of cannabinoids in eliciting cardiovascular depression
N Niederhoffer et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2003)
Endogenous cannabinoid, 2-arachidonoylglycerol, attenuates naloxone-precipitated withdrawal signs in morphine-dependent mice
TU Yamaguchi et al.
BRAIN RESEARCH (2001)
Bidirectional control of airway responsiveness by endogenous cannabinoids
A Calignano et al.
NATURE (2000)
Share Paper
